ABSTRACT
OBJECTIVE To analyze the situation and causes of the shortage of drugs in centralized volume-based procurement， and to put forward countermeasures and suggestions for optimizing centralized procurement rules and improving the drug shortage supply guarantee system. METHODS The shortage data of the first five batches of centralized purchasing drugs during January 2019 and December 2021 were collected from the Shortage Database of Chinese medicine economic information； descriptive statistical analysis was performed for shortage frequency， varieties and reasons. RESULTS & CONCLUSIONS After the first five batches of centralized volumetric procurement policy landed， the frequency of drug shortage reported for selected specifications and selected enterprises increased significantly， mainly drug shortage of selected enterprises. The shortage of some varieties from selected enterprises in the short term was obvious， and most of them were commonly used clinical drugs. The occurrence of drug shortages was affected by various links such as the production， circulation and use， and the main reasons were shortage or monopoly of raw materials. In order to ensure the drugs supply， the government should scientifically assess the risk of production interruption of enterprises， further optimize centralized procurement rules， improve the reporting system for drug shortages， and attach importance to the supply of key drugs； in addition， hospitals should take a variety of measures within the scopes of policies to flexibly respond to drug shortages so as to avoid delaying the treatment of patients.
ABSTRACT
The paper centered on the background,objectives,key actions of the policy and the relationships between policy objectives and key policy actions.Further analysis went on to the three phases of policy implementation and phased achievements,as well as the opportunities and challenges of the policy.These efforts aim at supporting sustainable development of the drug supply support model and hospital reform stage of greater risks and challenges with policy recommendations in Sanming city.
ABSTRACT
Government departments,pharmaceutical enterprises,health providers and patients were the four main stakeholders who involved in drug supply support reform in Sanming City.The paper centered on stakeholders' role and basic appeal,their influence on the reform or the influence of reform on them and the probable problems of reform,to make the motivation and resistance of the reform clearly and provide evidence for the sustainability and reproducibility of the reform.
ABSTRACT
Objective To develop a method for constructing a modularized support system of medical supplies for military operations other than war (MOOTW) and to evaluate its feasibility. Methods The existing disease/injury spectrum and the consumption information of medical supplies in MOOTW were collected. The medical supplies demand in MOOTW was divided into general demand, special demand, and supplement demand according to the principles of modularity, systems analysis, logical analysis and cluster analysis. And a modularized support system for medical supplies was subsequently designed. Results In accordance with the medical support missions and the analysis of loss due to noneffective, we constructed a modularized support system of medical supplies, which consisting of 32 basic modules in 4 categories. The catalogues of medical supplies for 7 common MOOTW missions were proposed based on the analysis of the consumption rules of medical supplies in MOOTW. The decision-making system for modularized support of medical supplies in MOOTW was designed in line with actual requirement of medical supply support in MOOTW. Conclusion Simulating test has demonstrated that the proposed decision-making system for modularized support of medical supplies in MOOTW can improve the flexibility, adaptability, and reliability of medical supply, and it is a new approach to implement precise medical supply support.